1.485
10.00%
-0.165
Evogene Ltd stock is traded at $1.485, with a volume of 123.88K.
It is down -10.00% in the last 24 hours and down -42.44% over the past month.
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment followed by Industry.
See More
Previous Close:
$1.65
Open:
$1.61
24h Volume:
123.88K
Relative Volume:
0.46
Market Cap:
$9.01M
Revenue:
$5.64M
Net Income/Loss:
$-23.88M
P/E Ratio:
-2.70
EPS:
-0.55
Net Cash Flow:
$-22.36M
1W Performance:
-15.14%
1M Performance:
-42.44%
6M Performance:
-79.52%
1Y Performance:
-76.43%
Evogene Ltd Stock (EVGN) Company Profile
Compare EVGN with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
EVGN | 1.4701 | 9.01M | 5.64M | -23.88M | -22.36M | -0.55 |
VRTX | 447.47 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 744.21 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 592.97 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 248.92 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 103.87 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Evogene Ltd Stock (EVGN) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Oct-08-21 | Initiated | ROTH Capital | Buy |
Jul-29-21 | Initiated | Aegis Capital | Buy |
Dec-01-20 | Initiated | Cantor Fitzgerald | Overweight |
Dec-16-13 | Initiated | Oppenheimer | Outperform |
Evogene Ltd Stock (EVGN) Latest News
Evogene earnings missed by $0.30, revenue fell short of estimates - Investing.com India
Evogene Sees Revenue Growth and Expands AI Collaboration - TipRanks
Evogene Reports Third Quarter 2024 Financial Results - PR Newswire
Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results - Marketscreener.com
Evogene's Bio-Fungicide Shows 70% Efficacy in Trials, Advances to Pre-Commercial Stage | EVGN Stock News - StockTitan
Evogene stock hits 52-week low at $1.7 amid market challenges - Investing.com India
Evogene subsidiary Lavie Bio announces commercial expansion of Yalos treatment - TipRanks
Finansavisen - Finansavisen
Evogene Schedules Third Quarter 2024 Financial Results Release - Marketscreener.com
Evogene (EVGN) to Report Q3 2024 Results, Hosts Virtual Conference Call Nov 21 | EVGN Stock News - StockTitan
Evogene Announces Collaboration with Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule Design - Krishak Jagat English
Evogene and Google Cloud Partner to Develop AI Foundation Model for Drug Discovery - HIT Consultant
Evogene stock hits 52-week low at $2.13 amid market challenges - Investing.com Australia
500: Something went wrong - Investing.com
Evogene partners with Google Cloud for AI-driven molecule design By Investing.com - Investing.com Australia
Evogene partners with Google Cloud for AI-driven molecule design - Investing.com India
Biomica to Present at Digestive Disease Week (DDW) Conference 20 - GuruFocus.com
Evogene announces collaboration with Google Cloud - MSN
Syngenta and Lavie Bio Announce Partnership to Discover and Deve - GuruFocus.com
Casterra Announces a Key Milestone in its Operational Expansion Plan in Africa, with Completion of First Shipment of Castor Seeds Grown and Processed in Kenya - Krishak Jagat English
Evogene Ltd. (NASDAQ:EVGN) Sees Significant Growth in Short Interest - MarketBeat
Evogene (NASDAQ:EVGN) Stock Crosses Below 200-Day Moving AverageShould You Sell? - MarketBeat
StockNews.com Begins Coverage on Evogene (NASDAQ:EVGN) - MarketBeat
Evogene stock hits 52-week low at $2.21 amid market challenges - Investing.com Nigeria
Evogene (NASDAQ:EVGN) Coverage Initiated by Analysts at StockNews.com - MarketBeat
Watershed, Evogene, and BGU to Expand Gene Editing Applications to White Leg Shrimp and Red Swamp Crayfish - ISAAA
Evogene (NASDAQ:EVGN) Shares Pass Below Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Evogene (NASDAQ:EVGN) Research Coverage Started at StockNews.com - MarketBeat
Watershed AC, Evogene and Ben-Gurion University Receive Approval for Second Year Grant to Continue the Collaboration Focused on Improving Crustacean Traits Utilizing Gene Editing Technology - PR Newswire
Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of ‘MicroFermentor’, a Unique Technology that Can Change the Economics of Ag-Biologicals - Krishak Jagat English
Lavie Bio receives grant to advance ag-biologicals tech - World Bio Market Insights
Evogene (NASDAQ:EVGN) Stock Price Crosses Below 200 Day Moving Average of $5.81 - MarketBeat
StockNews.com Initiates Coverage on Evogene (NASDAQ:EVGN) - MarketBeat
Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of 'MicroFermentor', a Unique Technology that Can Change the Economics of Ag-Biologicals - Lelezard
Evogene receives grant from IIA to advance development of ‘MicroFermentor’ - TipRanks
Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of 'MicroFermentor', a Unique Technology that Can Change the Economics of Ag-Biologicals – Company AnnouncementFT.com - Financial Times
Evogene stock hits 52-week low at $2.6 amid market challenges - Investing.com Canada
Casterra Announces Additional $2.2 Million of Purchase Orders to Supply Castor Seeds for New African Territories - GuruFocus.com
Biomica CEO Set to Attend JP Morgan Healthcare Week in San Franc - GuruFocus.com
Casterra Appoints New CEO and Expands Team to Drive Growth and I - GuruFocus.com
A Tale of Resilience: Evolv Technologies Holdings Inc Amid Stock Market Turbulence - The InvestChronicle
Evotec (NASDAQ:EVO) Sees Unusually-High Trading Volume - MarketBeat
Evogene Ltd Stock (EVGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):